209 related articles for article (PubMed ID: 25153136)
1. A molecular prognostic model predicts esophageal squamous cell carcinoma prognosis.
Cao HH; Zheng CP; Wang SH; Wu JY; Shen JH; Xu XE; Fu JH; Wu ZY; Li EM; Xu LY
PLoS One; 2014; 9(8):e106007. PubMed ID: 25153136
[TBL] [Abstract][Full Text] [Related]
2. A three-protein signature and clinical outcome in esophageal squamous cell carcinoma.
Cao HH; Zhang SY; Shen JH; Wu ZY; Wu JY; Wang SH; Li EM; Xu LY
Oncotarget; 2015 Mar; 6(7):5435-48. PubMed ID: 25605255
[TBL] [Abstract][Full Text] [Related]
3. Expression of cyclooxygenase-2, vascular endothelial growth factor, and epidermal growth factor receptor in Chinese patients with esophageal squamous cell carcinoma.
Cui Y; Dong C; Wu BQ; Duan XC; Shi G; Gong M; Wang TY
J Cancer Res Ther; 2015 Aug; 11 Suppl 1():C44-8. PubMed ID: 26323923
[TBL] [Abstract][Full Text] [Related]
4. A novel staging model to classify oesophageal squamous cell carcinoma patients in China.
Tan H; Zhang H; Xie J; Chen B; Wen C; Guo X; Zhao Q; Wu Z; Shen J; Wu J; Xu X; Li E; Xu L; Wang X
Br J Cancer; 2014 Apr; 110(8):2109-15. PubMed ID: 24569468
[TBL] [Abstract][Full Text] [Related]
5. MiR-613: a novel diagnostic and prognostic biomarker for patients with esophageal squamous cell carcinoma.
Guan S; Wang C; Chen X; Liu B; Tan B; Liu F; Wang D; Han L; Wang L; Huang X; Wang J; Yao B; Shi J; Chen P; Nesa EU; Song Q; Cheng Y
Tumour Biol; 2016 Apr; 37(4):4383-91. PubMed ID: 26499784
[TBL] [Abstract][Full Text] [Related]
6. Vav1 expression is increased in esophageal squamous cell carcinoma and indicates poor prognosis.
Zhu X; Jin H; Xia Z; Wu X; Yang M; Zhang H; Shang X; Cheng R; Zhan Z; Yu Z
Biochem Biophys Res Commun; 2017 Apr; 486(2):571-576. PubMed ID: 28336434
[TBL] [Abstract][Full Text] [Related]
7. Decreased Tumor Suppressor Candidate 3 Predicts Poor Prognosis of Patients with Esophageal Squamous Cell Carcinoma.
Yu X; Zhang J; Zhong H; Liu F; Liang N; Wang Y; Meng X; Du J
Int J Med Sci; 2016; 13(12):963-969. PubMed ID: 27994502
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of EGFR family expression in lymph node-negative esophageal squamous cell carcinoma patients.
Yu W; Yang X; Chu L; Zhao K; Chen H; Xiang J; Zhang Y; Li H; Zhao W; Sun M; Wei Q; Fu X; Xie C; Zhu Z
Pathol Res Pract; 2018 Jul; 214(7):1017-1023. PubMed ID: 29729836
[TBL] [Abstract][Full Text] [Related]
9. Expression of epidermal growth factor receptor is an independent prognostic factor for esophageal squamous cell carcinoma.
Wang Q; Zhu H; Xiao Z; Zhang W; Liu X; Zhang X; He J; Sun K; Wang L; Xu N
World J Surg Oncol; 2013 Oct; 11():278. PubMed ID: 24131756
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of fascin overexpression in human esophageal squamous cell carcinoma.
Hashimoto Y; Ito T; Inoue H; Okumura T; Tanaka E; Tsunoda S; Higashiyama M; Watanabe G; Imamura M; Shimada Y
Clin Cancer Res; 2005 Apr; 11(7):2597-605. PubMed ID: 15814639
[TBL] [Abstract][Full Text] [Related]
11. Protein-coding genes combined with long noncoding RNA as a novel transcriptome molecular staging model to predict the survival of patients with esophageal squamous cell carcinoma.
Guo JC; Wu Y; Chen Y; Pan F; Wu ZY; Zhang JS; Wu JY; Xu XE; Zhao JM; Li EM; Zhao Y; Xu LY
Cancer Commun (Lond); 2018 Apr; 38(1):4. PubMed ID: 29784063
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of SLC9A9 in patients with resectable esophageal squamous cell carcinoma.
Chen J; Wen J; Zheng Y; Yang H; Luo K; Liu Q; Hu R; Tan Z; Huang Q; Fu J
Tumour Biol; 2015 Sep; 36(9):6797-803. PubMed ID: 25835977
[TBL] [Abstract][Full Text] [Related]
13. A four actin-binding protein signature model for poor prognosis of patients with esophageal squamous cell carcinoma.
Peng ZM; Yu W; Xie Y; Peng WH; Cao HH; Shen JH; Wu ZY; Li EM; Xu LY
Int J Clin Exp Pathol; 2014; 7(9):5950-9. PubMed ID: 25337239
[TBL] [Abstract][Full Text] [Related]
14. The status of perineural invasion predicts the outcomes of postoperative radiotherapy in locally advanced esophageal squamous cell carcinoma.
Ning ZH; Zhao W; Li XD; Chen LJ; Xu B; Gu WD; Shao YJ; Xu Y; Huang J; Pei HL; Jiang JT
Int J Clin Exp Pathol; 2015; 8(6):6881-90. PubMed ID: 26261575
[TBL] [Abstract][Full Text] [Related]
15. A disintegrin and metalloproteinase 17 mRNA and protein expression in esophageal squamous cell carcinoma, as well as its clinicopathological factors and prognosis.
Liu HB; Yang QC; Shen Y; Zhu Y; Zhang XJ; Chen H
Mol Med Rep; 2015 Feb; 11(2):961-7. PubMed ID: 25351873
[TBL] [Abstract][Full Text] [Related]
16. Clinical potential of miR-3651 as a novel prognostic biomarker for esophageal squamous cell cancer.
Wang C; Guan S; Chen X; Liu B; Liu F; Han L; Un Nesa E; Song Q; Bao C; Wang X; Cheng Y
Biochem Biophys Res Commun; 2015 Sep; 465(1):30-4. PubMed ID: 26210449
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of tumor-infiltrating immune cells and PD-L1 expression in esophageal squamous cell carcinoma.
Jiang Y; Lo AWI; Wong A; Chen W; Wang Y; Lin L; Xu J
Oncotarget; 2017 May; 8(18):30175-30189. PubMed ID: 28404915
[TBL] [Abstract][Full Text] [Related]
18. Elevated expression of ΔNp63 in advanced esophageal squamous cell carcinoma.
Kumakura Y; Rokudai S; Iijima M; Altan B; Yoshida T; Bao H; Yokobori T; Sakai M; Sohda M; Miyazaki T; Nishiyama M; Kuwano H
Cancer Sci; 2017 Nov; 108(11):2149-2155. PubMed ID: 28892579
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of HSP47 in esophageal squamous cell carcinoma: clinical implications and functional analysis.
Lee HW; Kwon J; Kang MC; Noh MK; Koh JS; Kim JH; Park JH
Dis Esophagus; 2016 Oct; 29(7):848-855. PubMed ID: 25953518
[TBL] [Abstract][Full Text] [Related]
20. Prognostic implications of
Kwon D; Yun JY; Keam B; Kim YT; Jeon YK
World J Gastroenterol; 2016 Nov; 22(44):9803-9812. PubMed ID: 27956804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
